Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Sep 2, 2009


Michael Snyder has moved from Yale University to Stanford University, where he has become chair of the Department of Genetics. He will also lead a new Center of Genomics and Personalized Medicine, which will bundle school and university efforts in genomics and their application to diagnosing and managing human disease.

At Yale, which he joined as a faculty member in 1986, Snyder was most recently a professor of biology and director of the Yale Center for Genomics and Proteomics. From 1998 until 2004, he was chair of the Department of Molecular, Cellular, and Developmental Biology. Snyder holds a PhD from the California Institute of Technology and did a postdoctoral fellowship at Stanford with Ron Davis in the Department of Biochemistry.

Earl Collier has resigned from his post as a director of Decode Genetics, the company said in a recent filing with the US Securities and Exchange Commission. In the filing, Decode said that the resignation was not due to any disagreements he had with the company about operations or policies.

Illumina has named Christian Henry as vice president of corporate development, a newly created position. Henry will be responsible for all activities related to corporate and business development, strategic planning, and mergers and acquisitions, Illumina said. He has served as Illumina's chief financial officer since 2005.

Leroy Hood and George Church have joined Cellular Dynamics' scientific advisory board. the company is developing drug screening and toxicity testing products based on induced pluripotent stem cell technology.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more